TNFRSF10D and T-cell non-Hodgkin lymphoma: We next checked whether TRAIL-R4 ectopic expression affected cell proliferation in two other TRAIL-sensitive tumor cell lines, the Jurkat T cell lymphoma and the colon carcinoma SW480.